These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 20172407
1. Propranolol may become first-line treatment in obstructive subglottic infantile hemangiomas. Denoyelle F, Garabédian EN. Otolaryngol Head Neck Surg; 2010 Mar; 142(3):463-4. PubMed ID: 20172407 [No Abstract] [Full Text] [Related]
2. Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Denoyelle F, Leboulanger N, Enjolras O, Harris R, Roger G, Garabedian EN. Int J Pediatr Otorhinolaryngol; 2009 Aug; 73(8):1168-72. PubMed ID: 19481268 [Abstract] [Full Text] [Related]
3. Management of infantile subglottic hemangioma: acebutolol or propranolol? Blanchet C, Nicollas R, Bigorre M, Amedro P, Mondain M. Int J Pediatr Otorhinolaryngol; 2010 Aug; 74(8):959-61. PubMed ID: 20557953 [Abstract] [Full Text] [Related]
4. [Propranolol for treatment of subglottic hemangioma]. Kurzyna A, Hassmann-Poznańska E, Wójtowicz J, Bossowski A. Otolaryngol Pol; 2010 Aug; 64(6):388-91. PubMed ID: 21302508 [Abstract] [Full Text] [Related]
5. Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma. Truong MT, Chang KW, Berk DR, Heerema-McKenney A, Bruckner AL. J Pediatr; 2010 Feb; 156(2):335-8. PubMed ID: 20105647 [Abstract] [Full Text] [Related]
8. Propranolol for infantile hemangiomas. Bagazgoitia L, Torrelo A, Gutiérrez JC, Hernández-Martín A, Luna P, Gutiérrez M, Baño A, Tamariz A, Larralde M, Alvarez R, Pardo N, Baselga E. Pediatr Dermatol; 2011 Aug; 28(2):108-14. PubMed ID: 21385205 [Abstract] [Full Text] [Related]
10. Case report: Treatment failure using propanolol for treatment of focal subglottic hemangioma. Canadas KT, Baum ED, Lee S, Ostrower ST. Int J Pediatr Otorhinolaryngol; 2010 Aug; 74(8):956-8. PubMed ID: 20846505 [Abstract] [Full Text] [Related]
11. Open airway surgery for subglottic hemangioma in the era of propranolol: Is it still indicated? Siegel B, Mehta D. Int J Pediatr Otorhinolaryngol; 2015 Jul; 79(7):1124-7. PubMed ID: 26027725 [Abstract] [Full Text] [Related]
12. Propranolol for treatment of ulcerated infantile hemangiomas. Saint-Jean M, Léauté-Labrèze C, Mazereeuw-Hautier J, Bodak N, Hamel-Teillac D, Kupfer-Bessaguet I, Lacour JP, Naouri M, Vabres P, Hadj-Rabia S, Nguyen JM, Stalder JF, Barbarot S, Groupe de Recherche Clinique en Dermatologie Pédiatrique. J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332 [Abstract] [Full Text] [Related]
13. Treatment failure with propranolol for subglottic haemangioma. Liu Z, Yeo YH, Jackson C, Trimble K. BMJ Case Rep; 2019 May 13; 12(5):. PubMed ID: 31088811 [Abstract] [Full Text] [Related]
14. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study. Zvulunov A, McCuaig C, Frieden IJ, Mancini AJ, Puttgen KB, Dohil M, Fischer G, Powell J, Cohen B, Ben Amitai D. Pediatr Dermatol; 2011 May 13; 28(2):94-8. PubMed ID: 21362031 [Abstract] [Full Text] [Related]
15. Infantile Subglottic Hemangioma: A Case ReportInfantile Subglottic Hemangioma: A Case Report. Baniya R, Chaudhary A, Poudel Upadhyaya A, Rijal P. JNMA J Nepal Med Assoc; 2024 Feb 29; 62(271):211-213. PubMed ID: 39356782 [Abstract] [Full Text] [Related]
17. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls. Hermans DJ, van Beynum IM, Schultze Kool LJ, van de Kerkhof PC, Wijnen MH, van der Vleuten CJ. J Am Acad Dermatol; 2011 May 29; 64(5):833-8. PubMed ID: 21353329 [Abstract] [Full Text] [Related]
19. [Clinical observations on propranolol use for paediatric airway hemangiomas]. Santos S, Torrelo A, Tamariz-Martel A, Domínguez MJ. Acta Otorrinolaringol Esp; 2010 May 29; 61(5):365-70. PubMed ID: 20346430 [Abstract] [Full Text] [Related]
20. [Propranolol first choice in infantile hemangiomas. Large randomized trials are needed to determine the dosage and duration of treatment]. Wahlgren CF. Lakartidningen; 2010 May 29; 110(19-20):938-9. PubMed ID: 23745498 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]